Product Details:
Minimum Order Quantity | 1 Bottle |
Packaging Size | Box |
Strength | 90mg,400mg |
Composition | LEDIPASVIR OR SOFOSBUVIR |
Treatment | HEPATITIS |
Prescription/Non prescription | Prescription |
Brand | Aprazer |
Manufacturer | Glenmark Pharmaceuticals |
Form | Tablet |
Shelf life | More than 2 years |
Packaging Type | Bottles |
Ledikast( Ledipasvir& Sofosbuvir Tablets)
The fixed-dose combination of ledipasvir-sofosbuvir provides an effective and well-tolerated one-pill once-a-day option for treatment of genotypes 1, 4, 5, and 6 chronic hepatitis C (HCV) infection. This direct-acting antiviral regimen was the first FDA-approved interferon- and ribavirin free regimen to treat hepatitis C.
Additional Information:
4.2/5
Rated by 67 Users